A. Deans

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Inhaled Doses of Umeclidinium in Healthy Subjects: Two Randomized Studies

R. Tal-Singer, R. Mehta, K. Hardes, 2013, Clinical Drug Investigation.

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients

J. V. van Noord, R. Mehta, A. Cahn, 2012, International journal of chronic obstructive pulmonary disease.

Relationship between Pharmacokinetics and Pharmacodynamic Responses in Healthy Smokers Informs a Once-Daily Dosing Regimen for Nemiralisib

G. Dear, A. Kielkowska, A. Cahn, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of GSK573719 inhalation powder in healthy subjects

R. Tal-Singer, R. Mehta, D. Kelleher, 2011 .

Safety, tolerability and pharmacokinetics (PK) of single and repeat nebulised doses of a novel phosphoinositide 3-kinase δ inhibitor (PI3Kδ), GSK2269557, administered to healthy male subjects in a phase I study

A. Sousa, C. Rambaran, I. McSherry, 2013 .

Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.

P. Daley-Yates, R. Mehta, A. Sousa, 2022, Pulmonary pharmacology & therapeutics.